GSK

We are uniting science, technology and talent to get ahead of disease together.
Our community guidelines:

[GSK @GSK]

#News for #investors & #media: Today marks an important milestone in chronic hepatitis B (CHB), with the U.S. FDA approving a new therapy for people living with the disease.

This approval reflects years of research and a continued commitment to advancing innovation in liver disease, where significant unmet need remains.

Learn more: https://t.co/XmFbTBEC0m

[GSK @GSK]

#News for #Investors and #Media: The US Food and Drug Administration (FDA) has approved a new indication for one of our immunotherapies. Read more: https://t.co/r2x5AhMjHR

[GSK @GSK]

#News for #Investors and #Media: Today, we shared the first data for our investigational treatment for extensive-stage small-cell lung cancer in a global population.

Learn more: https://t.co/jD5wuwaHgi

#ESMO2026

[GSK @GSK]

#News for #Investors and #Media: At ESMO 2026, we're showcasing over 20 abstracts from our oncology portfolio and pipeline, underscoring our expansion into solid tumours like lung, gynaecological, gastrointestinal, and GIST.

Read more:https://t.co/2EHyMi3ydC

#ESMO2026

[GSK @GSK]

@PraveenKumGarg9 Hello Praveen, thanks for getting in touch.
Centrum is now made by Haleon, not GSK. We encourage you to reach out with further feedback or questions via their channel @Haleon_health or their website, https://t.co/nVW29kMR2D. Sorry we couldn't be of help this time.

[GSK @GSK]

@LifeOfSetinz Hello. Andrew liver salt is no longer made by GSK. We encourage you to reach out with further feedback or questions to Haleon via their channel @Haleon_health or their website, https://t.co/nVW29kMR2D. Sorry we couldn't be of help this time.

[GSK @GSK]

@2312cleaner Hi Rafael. Thank you for your interest in working with us. You can find out more about our available job opportunities on our website: https://t.co/zlMp9D57bA. Good luck with your job search!

[GSK @GSK]

Dementia is one of the greatest health challenges facing society today. We're proud to support The BARBARA Alliance in a major new partnership, announced today by UK Government, bringing together academia, charities and industry to help accelerate research.

Read more here: https://t.co/JqJJLcA2zw

[GSK @GSK]

@pushpendra_pk_ @GSK_bio @GSKUS Hi Pushpendra, thanks for getting in touch. ENO is now made by Haleon, not GSK. You can get in touch with them via their channel @Haleon_health or their website, https://t.co/nVW29kMR2D. Sorry we couldn't be of help this time.

[GSK @GSK]

#News for #Investors and #Media:

Today our specialist HIV company, @ViiVHC, announced phase III study results in #HIV evaluating a long-acting option versus daily oral therapy.

Our mission: to leave no person living with HIV behind.

👉 Find out more: https://t.co/NUEcN6Nvqx

[GSK @GSK]

@Pahadi_Anjana Thanks for bringing this to our attention. To ensure this is thoroughly investigated, please contact our GSK India team directly at [email protected]. They are best placed to gather all the necessary details and provide you with support.

[GSK @GSK]

@BruceF852682 Hi Bruce, thanks for getting in touch. In the interest of patient safety, we have forwarded your comment to our safety team. Please get in touch with us at: https://t.co/I4cIyo92ul or https://t.co/IKRAFsFkBH so we can learn more about the experience you reported. Thank you.

[GSK @GSK]

Hi @lewisct15. Animal research plays a small but vital role in the development of life-saving medicines and vaccines. When using animals, we follow scientific principles to ensure that we prevent or minimise pain and distress before, during, and after experimental procedures. Learn more about our company-wide policy: https://t.co/fW9pRwAZI4. We hope this helps.

[GSK @GSK]

#News for #investors and #media: We have entered a licence agreement with Chimagen Biosciences for an investigational T-cell engager for multiple myeloma, advancing our leadership ambitions in blood cancer.

Find out more: https://t.co/u74GA102H4

[GSK @GSK]

#News for #investors and #media: Today, we announced new positive data at #WCLC26 representing encouraging news for people living with ROS1-positive non-small cell lung cancer.

Learn more: https://t.co/0joi3O26if

[GSK @GSK]

#News for #investors and #media: Today, our licensor Hansoh Pharma presented positive data at #WCLC26 from a pivotal trial of an investigational antibody-drug conjugate in our pipeline.

Learn more: https://t.co/L67q0rxWZD

[GSK @GSK]

#News for #Investors and #Media: Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved a new prefilled syringe presentation of one of our vaccines.

Learn more: https://t.co/I4voyYO0Vg

[GSK @GSK]

The data we’ve shared at #ERSCongress underscores how much more we can achieve for respiratory patients when science and partnership come together.

Building on our proven track record of innovation, we’re accelerating our R&D programmes in COPD to target multiple inflammatory pathways, aiming for ambitious trial outcomes that look beyond the disease impact on the lungs so that we can transform outcomes for a broad range of patients, with varying severities of disease.

#ERSCongress

[GSK @GSK]

@Dinesh78979417 Hi Dinesh, thanks for getting in touch. Eno is now made by Haleon, not GSK. You can get in touch with them via their channel @Haleon_health or their website, https://t.co/nVW29kMR2D. Sorry we couldn't be of help this time.

[GSK @GSK]

#Media #Investors Climate change is one of the greatest threats to human health, and its impact on patients with respiratory health conditions should not be underestimated. Through advances in sustainable respiratory care, we’re making progress towards our environmental goals.

Read the media statement https://t.co/iVuXkI7Bzq

[GSK @GSK]

@gems770077 Thanks for taking the time to reach out to us. Please complete the following form so we can share this opportunity with the relevant team: https://t.co/eDWLvEFOCm. They'll reach out to you if they want to learn more. Thanks!